Works matching IS 14765810 AND DT 2022 AND VI 20 AND IP 2
Results: 24
Issue Information.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 1, doi. 10.1111/vco.12849
- Publication type:
- Article
Expression of Concern: Tumour necrosis factor‐alpha‐induced protein 8 (TNFAIP8) expression associated with cell survival and death in cancer cell lines infected with canine distemper virus.
- Published in:
- 2022
- Publication type:
- Correction Notice
Corrigendum.
- Published in:
- 2022
- Publication type:
- Abstract
Shear wave elastography of lymph nodes in dogs with head and neck cancer: A pilot study.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 521, doi. 10.1111/vco.12803
- By:
- Publication type:
- Article
Standardisation of canine meningioma grading: Inter‐observer agreement and recommendations for reproducible histopathologic criteria.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 509, doi. 10.1111/vco.12802
- By:
- Publication type:
- Article
Re‐irradiation of canine non‐lymphomatous nasal tumours using stereotactic radiation therapy (10 Gy x 3) for both courses: Assessment of outcome and toxicity in 11 dogs.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 502, doi. 10.1111/vco.12801
- By:
- Publication type:
- Article
Comparative gene expression study highlights molecular similarities between triple negative breast cancer tumours and feline mammary carcinomas.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 535, doi. 10.1111/vco.12800
- By:
- Publication type:
- Article
The role of toceranib phosphate in dogs with non‐mast cell neoplasia: A systematic review.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 362, doi. 10.1111/vco.12799
- By:
- Publication type:
- Article
Outcomes of dogs with thymoma treated with intensity modulated stereotactic body radiation therapy or non‐modulated hypofractionated radiation therapy.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 491, doi. 10.1111/vco.12797
- By:
- Publication type:
- Article
The expression of histone lysine demethylase 2B in canine hemangiosarcoma is associated with disease progression.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 529, doi. 10.1111/vco.12796
- By:
- Publication type:
- Article
DNA damage response proteins in canine cancer as potential research targets in comparative oncology.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 347, doi. 10.1111/vco.12795
- By:
- Publication type:
- Article
Outcome of dogs with bone marrow suppression secondary to Sertoli cell tumour.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 484, doi. 10.1111/vco.12794
- By:
- Publication type:
- Article
Ovariectomy reduces the risk of tumour development and influences the histologic continuum in canine mammary tumours.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 476, doi. 10.1111/vco.12793
- By:
- Publication type:
- Article
Establishment and characterisation of cell lines and xenograft mouse models of canine systemic histiocytosis and disseminated histiocytic sarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 465, doi. 10.1111/vco.12792
- By:
- Publication type:
- Article
Outcome in dogs with curative‐intent treatment of localized primary pulmonary histiocytic sarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 458, doi. 10.1111/vco.12791
- By:
- Publication type:
- Article
BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006–2019).
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 449, doi. 10.1111/vco.12790
- By:
- Publication type:
- Article
Statins downregulate YAP and TAZ and exert anti‐cancer effects in canine mammary tumour cells.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 437, doi. 10.1111/vco.12789
- By:
- Publication type:
- Article
Evaluation of lymphocyte‐specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 427, doi. 10.1111/vco.12788
- By:
- Publication type:
- Article
An aggressive CD4<sup>−</sup>CD8<sup>−</sup> T‐cell neoplasm in young English bulldogs.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 416, doi. 10.1111/vco.12787
- By:
- Publication type:
- Article
Comparison of response assessment in veterinary neuro‐oncology and two volumetric neuroimaging methods to assess therapeutic brain tumour responses in veterinary patients.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 404, doi. 10.1111/vco.12786
- By:
- Publication type:
- Article
Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 393, doi. 10.1111/vco.12782
- By:
- Publication type:
- Article
CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 381, doi. 10.1111/vco.12781
- By:
- Publication type:
- Article
Therapeutic potential of the cytosine deaminase::uracil phosphoribosyl transferase/5‐fluorocytosine suicide system for canine melanoma.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 372, doi. 10.1111/vco.12780
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 2, p. 1, doi. 10.1111/vco.12783
- Publication type:
- Article